Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Garazha

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Seminars in Cancer Biology|August 15, 2019
RNA sequencing for research and diagnostics in clinical oncologyAnton Buzdin, Maxim Sorokin, Andrew Garazha, et al.
Frontiers in Molecular Biosciences|April 1, 2022
Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney CancerAlexander Gudkov, Valery Shirokorad, Kirill Kashintsev, et al.
Frontiers in Oncology|May 3, 2021
Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing ProfilesNicolas Borisov, Anna Sergeeva, Maria Suntsova, et al.
Oncotarget|November 16, 2017
Gene expression and molecular pathway activation signatures of <i>MYCN</i>-amplified neuroblastomasIvan Petrov, Maria Suntsova, Elena Ilnitskaya, et al.
Computers in Biology and Medicine|January 30, 2025
Prospective trial of the Oncobox platform RNA sequencing bioinformatic analysis for personalized prescription of targeted drugsMaksim Sorokin, Andrew Garazha, Maria Suntsova, et al.
Aging|September 28, 2016
In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy stateAlexander Aliper, Aleksey V Belikov, Andrew Garazha, et al.
Cancers|February 28, 2020
Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent GlioblastomaElla L Kim, Maxim Sorokin, Sven Rainer Kantelhardt, et al.
Cancers|August 27, 2021
Algorithmically Deduced <i>FREM2</i> Molecular Pathway Is a Potent Grade and Survival Biomarker of Human GliomasMarianna Zolotovskaia, Victor Tkachev, Maxim Sorokin, et al.
Oncotarget|February 14, 2018
Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiationMaxim Sorokin, Roman Kholodenko, Anna Grekhova, et al.
Heliyon|March 22, 2021
DNA repair pathway activation features in follicular and papillary thyroid tumors, interrogated using 95 experimental RNA sequencing profilesUliana Vladimirova, Pavel Rumiantsev, Marianna Zolotovskaia, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Seminars in Cancer Biology|August 15, 2019
RNA sequencing for research and diagnostics in clinical oncologyAnton Buzdin, Maxim Sorokin, Andrew Garazha, et al.
Frontiers in Molecular Biosciences|April 1, 2022
Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney CancerAlexander Gudkov, Valery Shirokorad, Kirill Kashintsev, et al.
Frontiers in Oncology|May 3, 2021
Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing ProfilesNicolas Borisov, Anna Sergeeva, Maria Suntsova, et al.
Oncotarget|November 16, 2017
Gene expression and molecular pathway activation signatures of <i>MYCN</i>-amplified neuroblastomasIvan Petrov, Maria Suntsova, Elena Ilnitskaya, et al.
Computers in Biology and Medicine|January 30, 2025
Prospective trial of the Oncobox platform RNA sequencing bioinformatic analysis for personalized prescription of targeted drugsMaksim Sorokin, Andrew Garazha, Maria Suntsova, et al.
Aging|September 28, 2016
In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy stateAlexander Aliper, Aleksey V Belikov, Andrew Garazha, et al.
Cancers|February 28, 2020
Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent GlioblastomaElla L Kim, Maxim Sorokin, Sven Rainer Kantelhardt, et al.
Cancers|August 27, 2021
Algorithmically Deduced <i>FREM2</i> Molecular Pathway Is a Potent Grade and Survival Biomarker of Human GliomasMarianna Zolotovskaia, Victor Tkachev, Maxim Sorokin, et al.
Oncotarget|February 14, 2018
Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiationMaxim Sorokin, Roman Kholodenko, Anna Grekhova, et al.
Heliyon|March 22, 2021
DNA repair pathway activation features in follicular and papillary thyroid tumors, interrogated using 95 experimental RNA sequencing profilesUliana Vladimirova, Pavel Rumiantsev, Marianna Zolotovskaia, et al.
Pageof 5